SILVANA STAMEVSKI: Open Payments
NPI 1083318893 · PLYMOUTH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 15 payments from 9 companies in 2025. Trend: 2023 $287 · 2024 $293 · 2025 $392
Food & beverage: $292Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $122 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Endo USA, Inc. | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Avation Medical, Inc. | 1 | $37 |
| Olympus America Inc. | 2 | $34 |
| TOLMAR, INC. | 2 | $32 |
| Blue Earth Diagnostics | 1 | $19 |
| IMMUNITYBIO, INC. | 1 | $15 |
Products named: XIAFLEX, KEYTRUDA, Vivally System, iTIND System, JATENZO, ORGOVYX, GEMTESA, Xtandi.
Industry payments across MI — which companies pay providers there.
